Optional product analytics
With your permission, we use privacy-limited analytics to understand which research journeys work. We do not run advertising trackers or session replay. You can change this choice in Preferences. Read the Privacy Policy.
GE Vernova Inc.'s published Sell conclusion compares the analysis-date price with fair value and potential value. Read the full report for assumptions, evidence, and material risks.
| Market cap | $250.9B | |
|---|---|---|
| Revenue (ttm) | 44B | |
| Net income (ttm) | 10.4B | |
| EPS (ttm) | $38.3 | |
| Shares out | 266.3M | |
| P/E (trailing) | 22.9x | |
| P/E (forward) | 38.2x | |
| Dividend | $2.00 (0.23%) | |
| Volume | 5,680,986 | |
| Beta | 0.97 |
Recent price action with selectable time range.
| Item | P1 | P2 | P3 | P4 | P5 | Trend |
|---|---|---|---|---|---|---|
| Period | 2021-12-31 | 2022-12-31 | 2023-12-31 | 2024-12-31 | 2025-12-31 | Trend |
| Revenue | $33.01B | $29.65B | $33.24B | $34.94B | $38.07B | +3.6% |
| Gross profit | $4.95B | $3.46B | $4.82B | $6.09B | $7.54B | +11.1% |
| Operating income | $-692.0M | $-2.88B | $-923.0M | $471.0M | $1.39B | — |
| Net income | $-633.0M | $-2.74B | $-438.0M | $1.55B | $4.88B | — |
| EPS (diluted) | — | $-10.00 | $-1.60 | $5.58 | $17.69 | — |
| EBITDA | $484.0M | $-526.0M | $932.0M | $3.56B | $3.68B | +66.1% |
| R&D | $1.01B | $979.0M | $896.0M | $982.0M | $1.20B | +4.4% |
| SG&A | $4.82B | $5.36B | $4.85B | $4.63B | $4.95B | +0.7% |
Recent company headlines from major financial publishers.
This path preserves the operating recovery but does not assume protected pricing or an extended period of rapid growth. A sustained shortfall against the FY2027 outlook would disconfirm it.
Evidence would be continued estimate delivery, cash-backed profit and new demand visibility beyond FY2027. Weaker normalized margins or higher reinvestment would disconfirm this path.
| Ke ↓ / g → | 2.6% | 3.1% | 3.6% | 4.1% | 4.6% |
|---|---|---|---|---|---|
| 7.6% | $461 | $479 | $500 | $528 | $565 |
| 8.6% | $422 | $433 | $447 | $463 | $484 |
| 9.6% | $393 | $401 | $410 | $421 | $433 |
| 10.6% | $371 | $376 | $383 | $390 | $399 |
| 11.6% | $352 | $357 | $361 | $367 | $373 |
Upcoming earnings date and setup when available.
The rating each month's published research edition carried. A rating compares the price at analysis with the Fair value; it is not a record of whether the call was right.
| Year | Jan | Feb | Mar | Apr | May | Jun | Jul | Aug | Sep | Oct | Nov | Dec |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 2026 |
